Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Slow uptake of breast cancer screening in Brussels:

This article was originally published in Clinica

Executive Summary

In Brussels, 40% of women aged 50-69 years of age apply for breast cancer screening on their own initiative. A recently introduced breast screening programme, however, named Mammotest, encouraged just 9.5% of the remainder of the women in this age group to seek screening in 2005, compared with 8.8% in 2004. This means that some 50% of at-risk women in the Belgian capital are not being screened.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel